Martin Zalesak - Concepedia

Author

Martin Zalesak

Also Known As

M. Zalesak, Martin Zalesak

Publications

413

Citations

H-Index

Concepts

All Affiliations

Martin Zalesak is an author at Novartis (United States) specializing in hepatitis d, medicine, and health economics.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	33
2	Public Health	1	1	33
3	Epidemiology	1	1	33
4	Health Policy	1	1	33
5	Hepatology	1	1	33

Martin Zalesak

Publications

283

Citations

H-Index

Page 1

	Year	Citations
Higher Persistence in Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran Versus Warfarin Martin Zalesak, Kimberly Siu, Kevin Francis, Circulation Cardiovascular Quality and Outcomes	2013	149
Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study Amit Bar‐Or, Heinz Wiendl, Xavier Montalbán, Multiple Sclerosis Journal	2021	59
Current and Future Disease Progression of the Chronic HCV Population in the United States Martin Zalesak, Kevin Francis, Alex Gedeon, PLoS ONE Cms MedicareUnited StatesPreventive MedicineViral PersistenceViral Hepatitis	2013	33
Effect of ofatumumab versus placebo in relapsing multiple sclerosis patients from Japan and Russia: Phase 2 APOLITOS study Jun‐ichi Kira, Jin Nakahara, Takayoshi Kurosawa, Multiple Sclerosis Journal	2021	28
Serum Neurofilament Light Trajectories and Their Relation to Subclinical Radiological Disease Activity in Relapsing Multiple Sclerosis Patients in the APLIOS Trial Amit Bar‐Or, Xavier Montalbán, Xixi Hu, Neurology and Therapy	2022	14

Page 1